During the past decade, Mater Cancer Care Centre conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mater Cancer Care Centre" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Celgene" with 2 trials sponsored, "BeiGene" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Multitude Therapeutics Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mater Cancer Care Centre" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator and "Tigermed Consulting Co., Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mater Cancer Care Centre" are "Breast Cancer" (3 trials), "Ovarian Cancer" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Advanced Cancer" (1 trials) and "Advanced Carcinoma" (1 trials). Many other conditions were trialed in "Mater Cancer Care Centre" in a lesser frequency.

Most popular intervention types in "Mater Cancer Care Centre" are "Drug" (12 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "Placebo" (4 trials), "Nab-paclitaxel" (3 trials), "Atezolizumab" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mater Cancer Care Centre" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mater Cancer Care Centre". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mater Cancer Care Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mater Cancer Care Centre, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".